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Objective: We sought to determine whether damage after deep hypothermic circu-
latory arrest can be diminished by changing pump prime components when rein-
stituting cardiopulmonary bypass.
Methods: Fifteen piglets (2-3 months old) were cooled to 19°C by using the alpha-stat
pH strategy. Five were cooled and rewarmed without ischemia (control animals), and
the other 10 piglets underwent 90 minutes of deep hypothermic circulatory arrest. Of
these, 5 were rewarmed and reperfused without altering the cardiopulmonary bypass
circuit blood prime. In the other 5 animals, the bypass blood prime was modified
(leukocyte depleted, hypocalcemic, hypermagnesemic, pH-stat, normoxic, mannitol,
and an Na/H exchange inhibitor) during circulatory arrest before starting warm
reperfusion. Oxidant injury was assessed on the basis of conjugated dienes, vascular
changes on the basis of endothelin levels, myocardial function on the basis of cardiac
output and dopamine need, lung injury on the basis of pulmonary vascular resistance
and oxygenation, and cellular damage on the basis of release of creatine kinase and
aspartate aminotransferase. Neurologic assessment (score 0, normal; score 500, brain
death) was done 6 hours after discontinuing cardiopulmonary bypass.
Results: Compared with animals undergoing cardiopulmonary bypass without isch-
emia (control animals), deep hypothermic circulatory arrest without modification of
the reperfusate produced an oxidant injury (conjugated dienes increased 0.78 vs 1.71
absorbance (Abs) 240 nmol/L per 0.5 mL, P  .001 vs control animals), depressed
cardiac output (6.0 vs 4.0 L/min, P  .05 vs control subjects), prolonged dopamine
need (P  .001 vs control subjects), elevated pulmonary vascular resistance (74%
vs 197%, P  .05 vs control subjects), reduced oxygenation (P  .01 vs control
subjects), increased neurologic injury (56 vs 244, P .001 vs control subjects), and
increased release of creatine kinase (2695 vs 6974 U/L, P .05 vs control subjects),
aspartate aminotransferase (144 vs 229 U/L), and endothelin (1.02 vs 2.56 pg/mL,
P  .001 vs control subjects). Conversely, the oxidant injury was markedly limited
(conjugated dienes of 0.85  0.09 Abs 240 nmol/L per 0.5 mL, P  .001 vs
unmodified pump prime) with modification of cardiopulmonary bypass prime,
resulting in increased cardiac output (5.1  0.8 L/min), minimal dopamine need
(P .001 vs unmodified pump prime), no increase in pulmonary vascular resistance
(44% 31%, P .01 vs unmodified pump prime) or endothelin levels (0.64 0.15
pg/mL, P  .001 vs unmodified pump prime), complete recovery of oxygenation
(P  .01 vs unmodified pump prime), reduced neurologic damage (144  33, P 
.05 vs unmodified pump prime), and lower release of aspartate aminotransferase
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(124  23 U/L, P  .05 vs unmodified pump prime) and creatine kinase (3366 
918, P  .05 vs unmodified pump prime).
Conclusions: A global reperfusion injury after deep hypothermic circulatory arrest
was identified and changed. The injury is mediated by oxygen-derived free radicals,
resulting in organ and endothelial dysfunction. Modification of global organ and
endothelial damage is achieved by modifying the blood prime in the cardiopulmonary
bypass circuit to deliver a controlled global reperfusate when reinstituting bypass.
Reperfusion injury produces functional, met-abolic, and structural alterations followingreintroduction of blood after temporaryischemia.1-4 This damage after reperfusionis exaggerated when reperfusion takesplace in an uncontrolled manner with un-
modified (normal) blood.1,2 If the ischemia is prolonged,
this can result in cellular damage, with impairment of end-
organ function and an increase in morbidity and mortality.
The cardiac surgeon is in the unique position to counteract
this manner of reperfusion damage because the conditions
of reperfusion and the composition of the reperfusate are
under his or her direct control. Initial cardiac studies showed
substantial injury reduction by modifying (controlling) the
method of reperfusion after myocardial ischemia.1,2,5,6 Sub-
sequently, similar underlying principles of controlled reper-
fusion were also found to limit reperfusion damage in the
lung, kidney, and skeletal muscle.7-12
These focal studies made it clear that the principles of
controlled reperfusion can be applied to the entire body. Global
damage can result during efforts to repair certain congenital
defects, as well as during adult cardiac surgery, because an
interval of circulatory arrest may be needed to expedite surgi-
cal repair.13,14 If CPB is restarted in an uncontrolled fashion
with unmodified blood, as is the usual clinical practice, the
potential exists for a global reperfusion injury to occur in every
organ. Such an injury would explain why generalized edema
and multiple organ impairment are common after deep hypo-
thermic circulatory arrest (DHCA).13-15 Studies in individual
organs (heart, lung, kidney, and skeletal muscle), however,
have shown that the fate of ischemic tissue is determined more
by the method of reperfusion than by the duration of ischemia
itself.1,2,5-12 It may therefore be possible to limit this global
reperfusion injury after DHCA by applying the principles of
controlled reperfusion pioneered in individual organs.
The aims of this study were to determine whether a
global reperfusion injury occurs after DHCA and whether
this injury could be avoided with controlled reperfusion by
modifying the pump prime during the period of circulatory
arrest to produce a modified global reperfusate.
Materials and Methods
Fifteen 2- to- 3-month-old (29-35 kg) pigs were premedicated with
20 mg/kg ketamine and 0.25 mg/kg diazepam administered intra-
muscularly. Anesthesia was then achieved with inhaled isoflurane
and fentanyl (5 g/kg), and the lungs were ventilated with a
volume ventilator. All animals received humane care in compli-
ance with the Principles of Laboratory Animal Care, formulated by
the National Society for Medical Research, and the “Guide for the
Care and Use of Laboratory Animals,” prepared by the National
Academy of Sciences and published by the National Institutes of
Health (publication No. 96-03, revised 1996).
The femoral artery and vein were cannulated to monitor arterial
pressure for blood gas determinations and for intravenous infusions.
After systemic heparinization (3 mg/kg), a thin-walled 18F to 20F,
52-cm-long venous cannula (Baxter Healthcare Corp, Irvine, Calif)
was inserted into the femoral vein to the level of the right atrium, and
a 14F to 16F thin-walled cannula was inserted into the femoral artery.
A second 18F to 20F short venous cannula was placed into the right
external jugular vein, and a Swan-Ganz catheter (Baxter) was placed
into the pulmonary artery through the internal jugular vein to measure
cardiac output. Arterial blood gases, electrolytes, and hemoglobin
levels (Blood Gas System 288; Ciba Corning, Midfield, Mass) were
measured every 15 to 30 minutes to ensure optimal levels. A heating-
cooling blanket was placed below the pig, and a second pad was
placed on the abdomen to maintain a constant core temperature of
37°C to 38°C when warm and 19°C during circulatory arrest. The
cardiopulmonary bypass (CPB) circuit was heparinized, primed with
packed red cells from donor pigs, and made normocalcemic. The
hematocrit value was adjusted to 25% to 35% with donor blood and
Plasmalyte solution (Baxter). A Baxter Univox Membrane Oxygen-
ator (Baxter) was used, and the systemic flow rate was adjusted to
approximately 100 to 125 mg  kg1  min1 at full flow to maintain
a continuously monitored aortic root pressure of 50 to 70 mm Hg.
Experimental Protocol
All animals were started on CPB with a fraction of inspired oxygen
(Fio2) of 100%, cooled to 19°C by using the alpha-stat strategy,
and separated into 3 experimental groups. In 5 pigs CPB was
continued without ischemia (control animals), whereas the other
10 animals underwent 90 minutes of DHCA. After DHCA, bypass
was restarted at a pressure of 20 to 30 mm Hg and slowly increased
to 50 to 70 mm Hg. All pigs were then rewarmed to 36°C or 37°C.
The heart was defibrillated as needed at 25°C, and all animals were
started on 10 g  kg1  min1 dopamine once the core temper-
ature reached 35°C. Dopamine was then either increased or
weaned to keep systolic arterial pressure greater than 70 mm Hg
and was discontinued only when arterial pressure was maintained
at greater than 70 mm Hg for 5 minutes. Hemodynamic and
pulmonary measurements were obtained before (baseline) and 60
minutes after CPB. Biochemical measurements were made before
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CPB (baseline), at 15 minutes of rewarming (conjugated dienes
[CD] and endothelin1), and 4 hours after CPB was discontinued
(creatine kinase [CK] and aspartate aminotransferase [AST]). Af-
ter the hemodynamic measurements, protamine was given, and all
cannulas were removed. Bleeding was controlled, the vessels were
repaired, and all wounds were closed. The animals were then
allowed to regain consciousness, were extubated, and underwent
neurologic assessment approximately 4 hours later (6 hours after
CPB). Fentanyl (0.2-0.3 g/kg) was given as needed for postop-
erative pain but was held for at least 2 hours before the neurologic
evaluation. The animals were then killed with 30 mg/kg pheno-
barbital and potassium chloride.
Experimental Groups
Control animals. Five pigs were cooled (19°C) and rewarmed
by using the alpha-stat strategy and an FIO2 of 100%, without any
ischemia or period of circulatory arrest.
DHCA. After cooling to 19°C with the alpha-stat strategy and
an FIO2 of 100%, the other 10 pigs underwent 90 minutes of
DHCA and were reperfused by using either the unmodified blood
prime or a modified global reperfusate.
Unmodified CPB prime. CPB was reinstituted in 5 pigs with-
out altering the pump blood bypass prime, oxygen concentration
(100%), or pH strategy (alpha-stat), and the animals were re-
warmed. This simulates the usual clinical practice.
Modified CPB prime. In the other 5 animals, the CPB prime
was modified during the period of circulatory arrest to make a
modified global reperfusate (Table 1). This included adding citrate
to reduce the ionized calcium concentration to 0.2 to 0.5 g/dL
and magnesium sulfate to increase the ionized magnesium con-
centration to 2 to 4 mEq/L, reducing the oxygen tension (PO2) to
80 to 100 mm Hg (normoxic strategy) and changing to a pH-stat
management for the first 10 minutes of reperfusion, and adding a
sodium-hydrogen ion exchange inhibitor (HOE 642, 5 mg/kg) and
mannitol (12.5 g). The bypass prime was also leukocyte depleted
by circulating the blood prime through 3 parallel conditioned
blood reperfusion application (CoBRA) filters (Pall B-1328 filter;
Pall Corporation, East Hills, NY) for 20 minutes during DHCA
and an LG-6 high-flow leukocyte-depleting filter (Pall Corp, East
Hills, NY) placed in the arterial line to continue white blood cell
(WBC) removal during the entire period of rewarming.
Physiologic and Biochemical Determinations
Hemodynamic measurements. Hemodynamic measurements
were made before and 60 minutes after discontinuing CPB. Car-
diac output was determined by means of duplicate injections of
4°C cold saline solution into the Swan-Ganz catheter. Cardiac
output and pulmonary vascular resistance were calculated as pre-
viously described.7,10,12,16,17 Dopamine requirements are expressed
as the total dose each animal received and calculated as the
summation of the dose per minute multiplied by the total number
of minutes at each dose.
Oxygenation. To assess pulmonary alveolar damage, the PO2
was obtained on 100% oxygen before (baseline) and 1 hour after
CPB by using a tidal volume of 12 to 15 mL/kg, and the ventilator
rate was adjusted to maintain a PCO2 of 36 to 44 mm Hg. Postop-
erative values are expressed as a percentage change from baseline,
with each pig acting as its own control.
Conjugated dienes. CD, which are a marker of oxidant-medi-
ated lipid peroxidation, were determined as previously described
and expressed as the absorbance at a wave length of 240 nm/0.5
mL plasma.16,17
CK and AST. Cellular injury was determined by measuring
CK and AST activity with the UV-spectrophotometric method
(Sigma Chemical Co, St Louis, Mo) and expressed as units per
milliliter of plasma.
Endothelin-1. Vascular injury was determined by measuring
endothelin levels with an Enzyme Immunometric Assay (ACE
EIA Kit; Cayman Chemical Co, Ann Arbor, Mich) and expressed
as picograms per milliliter of plasma.
Neurologic injury. Neurologic assessment was performed in
all animals approximately 4 hours after wounds were closed, and
the animals were extubated (6 hours after bypass). An adaption of
neurologic deficit scoring described elsewhere was used, and a
summary of the variables assessed are listed in Table 2.18 In
neurologic deficit scoring, 5 general components of the neurologic
examination are evaluated, and a score of 100 is assigned to each
category. A total score of 500 indicates brain death, whereas a
score of 0 is normal. Neurologic deficit scoring was not blinded but
was always agreed on by 2 members of the laboratory team. All
animals were also kept under close supervision for any clinical
evidence of seizure activity.
TABLE 1. Modified global reperfusate
Component Modified
Oxygen Normoxia (PO2 80-100 mm Hg)




Edema Mannitol (12.5 g)
Na/H exchange inhibitor HOE 642 (5 mg/kg)
WBC WBC filtration
CoBRA filter - bypass prime
LG-6 filter - arterial line
TABLE 2. Neurologic deficit scoring system
A. Central nerve function (0-100 points)
Pupil size (0-5), light reflex (0-5), eye position (0-5), lid reflex
(0-5), corneal reflex (0-5), ciliospinal reflex (0-5),
oculocephalic reflex (0-5), auditory reflex (0-10), gag reflex
(0-10), carinal reflex (0-15)
B. Respiration (0-100 points)
Normal (0), hyperventilation (25), abnormal (50), absent (100)
C. Motor sensory function (0-100 points)
Stretch reflex (0-25), motor response to pain (0-25),
positioning (0-25), muscle tonus (0-25)
E. Level of consciousness (0-100 points)
Normal (0), cloudy (30), delirium (45), stupor (60), coma (100)
F. Behavior (0-100 points)
Drinking (0-15), chewing (0-15), sitting (0-15), standing (0-15),
walking (0-40)
Total score is sum of all sections (0, normal; 500, brain death). Numbers in
parentheses indicate scores for each parameter.
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Data were analyzed by using JMP V2.0 software (SAS Institute,
Inc, Cary, NC) on a Macintosh IIVX computer (Apple Inc, Cu-
pertino, Calif). The paired Student t test was used for comparison
of variables among experimental groups. Group data are expressed
as means  SEM.
Results
Results are shown in Table 3 and Figures 1 to 3. No
difference between groups was noted for baseline values of
cardiac output (4.1  0.1 L/min), pulmonary vascular re-
sistance (385  20 dynes  s1  cm1  m2), PO2 on 100%
oxygen (521  16 mm Hg), CD (0.62  0.06 Abs 240
nmol/L), endothelin-1 (0.80  0.08 pg/mL), CK (263  23
U/L), or AST (22  9 U/L). There was also no difference
between groups for the cooling (36  1 minutes) or re-
warming (69  5 minutes) times.
Hemodynamic and Pulmonary Measurement
Postbypass cardiac output was excellent in both nonisch-
emic (control) pigs and those receiving a modified reperfu-
sate after DHCA. It was increased from baseline values,
which probably represents the normal response as a result of
higher endogenous catecholamines. These groups also re-
quired only low-dose dopamine to maintain adequate he-
modynamics, and dopamine was discontinued by the time
of cardiac output measurements in all animals. Likewise,
the pulmonary vascular resistance was only mildly in-
creased, and these animals sustained no significant alveolar
damage because there was no change in postoperative ox-
ygenation. In contrast, pigs receiving an unmodified reper-
fusate after DHCA had significantly higher dopamine re-
quirements to maintain adequate hemodynamics. The
cardiac output was lower despite 4 or 5 pigs still receiving
dopamine at the time of the measurements. In addition,
these pigs had markedly elevated pulmonary vascular resis-
Figure 1. Oxidant injury, as measured by conjugated dienes pro-
duction 15 minutes after initiating rewarming of CPB, is shown.
* P<.001 versus control; ** P<.001 versus unmodified prime.
Figure 2. Vascular injury, as assessed by means of endothelin-1
(ET-1) release 15 minutes after initiating rewarming on CPB, is
shown. * P<.05 versus control; ** P<.001 versus unmodified prime.






(n  5) Statistical significance
Physiologic
Cardiac output (L/min) 6.0 1.1 4.0 0.3* 5.1 0.8† *P .05 †P NS
Total dopamine requirement (g/kg) 325 150 1620 322* 323 31† *P .001 †P .001
Pulmonary vascular resistance (% increase) 74 48 197 49* 44 21† *P .05 †P .01
Oxygenation (% recovery) 95 4 61 8* 100 13† *P .01 †P .01
Biochemical
Cd (Abs 240nmol/L) 0.78 .12 1.71 0.10* 0.85 0.09† *P .001 †P .001
ET-1 (pg/mL) 1.02 0.05 2.56 0.12* 0.64 0.15† *P .001 †P .001
CK (U/mL) 2695 920 6974 2064* 3366 918† *P .05 †P .05
AST (U/mL) 144 25 229 67* 124 23† *P NS †P .05
Neurologic
Deficit score (0-500) 56 10 244 34* 144 33† *P .001 †P .05
NS, Not significant.
* Control versus unmodified.
† Unmodified versus modified.
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tance and alveolar capillary damage, as demonstrated by a
reduced recovery of postoperative oxygenation.
Biochemical Measurement
No increased CD or endothelin-1 efflux occurred in control
(nonischemic) pigs or those undergoing DHCA with a mod-
ified reperfusate. Likewise, there was only a small increase
in AST and a moderate increase in CK levels, indicating
little tissue damage. In contrast, pigs undergoing DHCA
with an unmodified reperfusate sustained a significant oxi-
dant and vascular injury, with a marked increase in CD and
endothelin-1 production. In addition, there was a substantial
increase in both AST and CK levels, signifying significant
tissue injury.
WBC Count
The prebypass total WBC count was 5.5  0.7  103
cells/mm3, which was not statistically different between
groups. The WBC count was reduced with CPB to 3.5 
0.4  103 cells/mm3 by the end of cooling but was once
again not significantly different between groups. However,
in pigs receiving modified reperfusion, the WBC count
decreased to 0.2  0.1  103 cells/mm3 after filtering the
bypass prime through the CoBRA filters. Five minutes after
rewarming, the WBC count increased to only 1.6  0.6 
103 cells/mm3 in the leukocyte-depleted pigs, whereas the
WBC count increased to 4.5  0.9  103 cells/mm3 in the
unfiltered nonischemic (control) and DHCA animals receiv-
ing an unmodified reperfusate. Four hours after bypass was
discontinued, the WBC remained slightly lower in pigs
receiving a modified reperfusate with leukocyte depletion
(6.3  1.1  103 cells/mm3) compared with that seen in
control and unmodified pigs (7.9  1.4  103 cells/mm3),
but this was not statistically different (P  .2) and was
higher than prebypass levels in all groups.
Neurologic Function
In nonischemic (control) pigs postoperative neurologic
function was almost completely normal, with minimal im-
pairment (Figure 3). However, pigs receiving an unmodified
reperfusate after circulatory arrest had severe neurologic
impairment, indicating substantial neurologic damage. They
all had a severely depressed level of consciousness and were
unable to stand or walk. In addition, 2 of 5 animals expe-
rienced generalized tonic clonic seizure activity. In contrast,
the neurologic injury was substantially reduced in pigs
receiving a modified reperfusate, resulting in significantly
less neurologic impairment and no postoperative seizure
activity. These pigs only had mild alterations in their levels
of consciousness and were usually able to stand and walk.
Discussion
Clinical reports show that deep DHCA can increase mor-
bidity and mortality by adversely changing postoperative
organ function through ischemia and reperfusion damage, a
presumably unavoidable consequence of DHCA.13-15,19,20
Our study confirmed that DHCA, followed by normal blood
reperfusion (uncontrolled), produces vascular, tissue, and
neurologic damage, with cardiac and pulmonary dysfunc-
tion. In contrast, controlled reperfusion with a modified
reperfusate limits the formation of oxygen-derived free rad-
icals, resulting in preservation of vascular, cardiac, pulmo-
nary, and neurologic function.
We and others have shown that negative consequences of
unmodified blood can be substantially avoided in isolated
studies of the heart, lung, kidney, and skeletal muscle by
controlling the initial period of reperfusion.1,2,5-12 Our
global results are consistent with prior observations of the
effects of controlled reperfusion in isolated organs. Con-
trolled reperfusion has not previously been studied globally
or locally in the brain. This study indicates that the princi-
ples of controlled reperfusion are effective in the brain
because the neurologic score was significantly improved
with a modified reperfusate, and no pig had seizures. A
potential drawback is that we did not examine the brain
histologically or look at biochemical markers of brain injury
(ie, S-100 protein or neuron-specific enolase). Neurologic
deficit scoring, however, directly correlates with pathologic,
as well as biochemical, markers of injury.18,20-22 A similar
correlation has also been seen with the production of oxy-
gen-derived free radicals, which were substantially reduced
with controlled reperfusion.
A second potential limitation is that the observation
period was limited, with a neurologic assessment only per-
formed 6 hours after bypass. However, leukocyte depletion
alone has been shown to significantly reduce neurologic
damage after DHCA in animals observed for up to 7 days.22
Figure 3. Neurologic injury 6 hours after discontinuing CPB, as
assessed by means of neurologic deficit scoring, is shown. A
score of 0 is defined as normal, and a score of 500 is defined as
brain dead. Note the severe neurologic impairment in pigs un-
dergoing circulatory arrest receiving an unmodified prime. In
contrast, neurologic injury was significantly reduced in pigs
receiving a modified prime after DHCA (see text for details).
* P<.001 versus control; ** P<.05 versus unmodified prime.
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Moreover, these investigations used a Pall LG-6 filter,
which is relatively inefficient. In contrast, by using more
efficient filters (as was done in the present study), as well as
by modifying the constituents of the solution, vastly im-
proved results in individual organs have been
shown.2,4,7,11,12,23,24 We therefore believe that even in the
absence of biochemical or histologic data, our findings
confirm that controlled reperfusion significantly reduces
neurologic injury. However, future studies will be needed to
more precisely define the role of controlled reperfusion in
limiting neurologic damage.
Each modification of the bypass prime was based on the
principles established in individual organs.1,2,4,7,10,12 Cal-
cium is one of the primary mediators of the reperfusion
injury and may be the common pathway leading to cellular
death.2,25 Reperfusion hypocalcemia was modulated in sev-
eral ways. Citrate was added to directly reduce the ionized
calcium levels. Magnesium levels were increased to both
reduce intracellular calcium levels by inhibiting calcium
entry across cellular membranes and to displace calcium
from binding sites of the sarcolemmal membrane.4,26 Post-
ischemic calcium entry is further limited because magne-
sium prevents the influx of sodium, which, during reperfu-
sion, is exchanged for calcium. This Na/H exchange
mechanism was also addressed by providing a (HOE 642)
sodium hydrogen ion exchange inhibitor. Ischemia and hyp-
oxia produce intracellular acidosis from anaerobic glycoly-
sis. The sodium hydrogen ion antiporter becomes activated
in an attempt to correct this acidosis, leading to sodium
overload.27,28 This sodium overload results in an intracellu-
lar calcium overload with reperfusion because sodium is
exchanged for calcium. Exchange inhibitors, such as HOE
642, selectively block this antiporter, paradoxically preserv-
ing the intracellular acidosis but avoiding intracellular hy-
percalcemia and its associated injury.27,28
The pH of the reperfusate was changed to pH-stat
through the initial period of reperfusion to further limit
sodium hydrogen ion exchange and calcium deposition by
means of the same mechanism. Mannitol was added to
reduce edema and may also be beneficial because it is a
potential oxygen radical scavenger.2 The specific benefits of
individual components is unknown because these factors
interact. Each component was found to be important in
individual organs, and for this reason, we applied these
individual principles in an integrated way in constructing
the global modified solution used in this study.1,2,4
Although WBCs are involved mainly in the maintenance
of the immune system, under certain pathologic conditions
of altered physiology, they may cause damage to myocar-
dial, pulmonary, or vascular tissue.4,7,23,24 Leukocyte depletion
is a readily available method that allows the surgeon to safely
minimize the harmful effects of neutrophils, without risking
side effects of pharmacologic interventions aimed at altering
leukocyte function or preventing the free radical injury through
the use of exogenous oxygen radical scavengers. WBCs have
a variety of deleterious effects.4,7,23,24,29 Under conditions of
hypoxemia or ischemia, vascular endothelium expresses sites
that bind neutrophils on reperfusion. Once bound, the neutro-
phil may be activated by several different mechanisms. The
bound, activated neutrophil is then involved in pathways that
contribute to cellular injury in addition to releasing substances
that are chemotactic for other neutrophils and macrophages,
resulting in an amplification of the inflammatory response.
Although WBCs can injure tissue by means of several mech-
anisms, numerous studies have demonstrated that the produc-
tion of oxygen radicals is probably the major factor responsible
for cellular damage.4,7,12,23,24,29 This explains the reduction in
oxygen-derived free radical formation (lower CD) in pigs
receiving leukocyte depletion, as well as the reduction in
vascular damage (decreased endothelin-1), because activated
WBCs cannot bind to the vascular endothelium if they are
removed.
Leukocyte depletion was accomplished by using 2 dif-
ferent types of filters. First, a CoBRA filter was used during
circulatory arrest to completely leukocyte deplete the by-
pass prime. The CoBRA filter is extremely efficient and
removes greater than 99% of WBCs in a single pass.30 It
also attenuates the membrane attack complex, which can
damage membranes directly. However, the CoBRA filter
can only accommodate flows of up to 150 mL/min and
becomes fully saturated after 500 to 750 mL of blood. We
therefore, used 3 CoBRA filters in parallel to completely
leukocyte deplete the prime. We strongly believe blood in
the bypass prime should always be completely leukocyte
depleted because oxygen-derived free radical formation is
greatest with the initial reintroduction of oxygen and blood
during reperfusion.7,23,24,29 An LG-6 filter was placed in the
arterial line to continue the beneficial effects of leukocyte
depletion. This filter can accommodate flows of up to 6
L/min for 1 to 2 hours before becoming saturated. It is less
efficient in removing WBCs and instead removes neutro-
phils slowly over time. It also does not attenuate the mem-
brane attack complex. The LG-6 filter, however, removes a
significant number of WBCs at lower flow rates (1-2 L/min)
because WBC removal is flow dependent. Therefore, an
LG-6 filter is still very effective at reducing leukocytes in
infants and small children. Use of inefficient WBC filters,
coupled with leukocyte depletion during times that are less
critical, probably explains why some investigators have
failed to demonstrate a clinical advantage with WBC filtra-
tion, despite overwhelming experimental evidence to their
benefit.7,12,23,24 Clearly, a more efficient in-line arterial filter
that substantially reduces leukocyte counts in a single pass
over the entire bypass run would be ideal. However, until
such filters are commercially available, clinical improve-
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ment will probably only be seen when WBC filters are used
in a specific manner and directed at distinct events.
The management of blood pH during CPB remains a
source of controversy and a subject of considerable recent
clinical and laboratory investigations. Surgeons have some-
times taken adversarial approaches to pH management dur-
ing DHCA, advocating either pH-stat or alpha-stat exclu-
sively. Each strategy has its own advantage, and they may
be integrated.13,14,19-22,31 pH-stat results in cerebral vasodi-
latation with more homogeneous brain perfusion, as well as
more rapid cooling and rewarming. However, by leaving the
cell in an acidic environment, pH-stat inhibits cellular me-
tabolism during ischemia. An alternative may be pH-stat
during cooling, followed by alpha-stat before circulatory
arrest to delay evolving acidosis during ischemia. In con-
trast, alpha-stat causes cerebral vasoconstriction and re-
duced cerebral perfusion, leading to longer cooling and
rewarming times. This may be particularly detrimental in
the setting of increased pulmonary collaterals that compete
for blood flow when perfusion pressure is fixed by CPB
flow rate. The more alkaline pH of alpha-stat reduces pul-
monary resistance and increases cerebral resistance, thereby
increasing competition for blood flow between the cerebral
and the pulmonary circulation. However, maintaining a
more alkaline environment by means of late alpha-stat can
help preserve and optimize enzymatic function in the face of
ischemia. Therefore, a combined approach takes advantage of
the strength while minimizing the weakness of each strategy.
We used an alpha-stat strategy in this study because it is
commonly used in numerous institutions and is probably
superior during the period of circulatory arrest because it
preserves cellular metabolism during ischemia.13,14,19,20,22,31
A pH-stat strategy was used in the modified reperfusion
group for the first 10 minutes of reperfusion to limit sodium
hydrogen ion exchange and calcium deposition. Although
pH-stat is probably also the optimal method for cooling and
rewarming, it was only used for the first 10 minutes of
rewarming to limit the differences between experimental
groups. However, we believe that the ideal approach would
be to integrate these 2 strategies by using pH-stat for longer
intervals of cooling, rewarming, and reperfusion and to use
alpha-stat just before the period of circulatory arrest. This may
mimic hyperventilation before apnea, a helpful strategy.
A similar adversarial approach has occurred with oxygen
strategy. Hyperoxia substantially increases an oxygen-me-
diated injury after hypoxia or ischemia.16,17,23,29 In contrast,
maintaining normoxia (PO2 of 80-100 mm Hg), rather than
hyperoxia, during the initiation of CPB can substantially
reduce oxidant damage and decrease the extent of tissue
injury.16,23 These benefits coincide with the PO2-dependent
nature of the injury because free radical production and
myocyte injury after reoxygenation or reperfusion of iso-
lated heart preparations are proportional to PO2.16,23 In clin-
ical practice, hyperoxic bypass is performed routinely but
likely never needed because a PO2 value of greater than 100
to 150 mm Hg confirms only a negligible increase in oxygen
content and has been associated with an impairment in
peripheral perfusion.23,32 The only exception is during a
period of DHCA, when high oxygen levels have been
shown to improve neuroprotection.19,33 However, these
same studies found that initiating CPB after DHCA with a
normoxic strategy significantly reduced formation of oxy-
gen-derived free radicals. Therefore, as with pH strategy, an
integrated approach making use of both normoxic and hy-
peroxic management probably provides the optimal therapy.
This may provide balance through hyperoxia before arrest
(DHCA) to raise cerebral PO2 levels and slow depletion
during ischemia: a preischemic preconditioning mechanism.
Conversely, normoxic reperfusion can limit oxidant injury
because flow is ensured by the CBP circuit.
Pigs in this study underwent 90 minutes of DHCA,
which is significantly longer than what is commonly used in
the clinical setting. However, these were normal, unstressed
pigs. In contrast, most patients with cardiovascular disease
are stressed by a variety of factors (ie, hypoxia, ischemia,
acidosis, or pressure-volume overload) that may make them
substantially less tolerant to the ischemic insult of DHCA. A
similar evolution may occur in adults subjected to circula-
tory arrest (ie, aortic aneurysm procedures).
Even with a shorter period of circulatory arrest, any
injury is unacceptable in the brain, which is extremely
sensitive to ischemia and reperfusion. In addition, when
combined with other necessary interventions (ie, cardiople-
gic arrest or prolonged CPB), a shorter period of circulatory
arrest may still adversely affect the postoperative function
in less susceptible organs.
Controlled reperfusion is not just changing the reperfu-
sate but also the conditions of reperfusion.1,2,10 A lower
initial reperfusion pressure (20-30 mm Hg) has been shown
to reduce cellular damage in the heart, lung, and
brain.2,4,10,14 When given before ischemia (pretreatment),
numerous substances have also been found to lessen the
reperfusion injury. For instance, sodium hydrogen ion ex-
change inhibitors (HOE 642) are much more effective if
given before ischemia.27,28 In a sense, 100% oxygen is a
pretreatment because it leaves the cell in an environment for
maximal energy production and reduces the damage during
ischemia. Using the same low perfusion pressure in both
groups and, with the exception of 100% oxygen, avoiding
pretreatment allowed us to examine the effects of the global
reperfusate, without other compounding variables. How-
ever, lower initial pressure and pretreatment are both im-
portant adjuncts in limiting reperfusion damage and should
always be used in concert with a modified reperfusate.
In conclusion, this study confirms that a reperfusion
injury occurs after DHCA and demonstrates that it can be
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significantly avoided by controlling the initial period of
reperfusion with a global modified prime. Incorporating this
modality will allow surgeons to reduce the damage after
DHCA, leading to a significant reduction in morbidity and
mortality and improved patient outcome.
We thank Ms Christina Green for her organizational and sec-
retarial assistance.
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Discussion
Dr Edward D. Verrier (Seattle, Wash). Which of the components
makes the difference?
Dr Allen. I am often asked this question when I talk about our
cardioplegic (reperfusate) solution, which is the basis for this
approach. The answer is, every component is important. White cell
filtration probably results in the biggest improvement, but every
component makes a difference. Each acts in a specific way to limit
the reperfusion injury. It is like asking what is the most important
instrument in an orchestra. The answer is the one that is missing.
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